Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 6
1999 7
2000 2
2001 2
2002 2
2003 2
2004 6
2005 6
2006 3
2007 4
2008 2
2009 2
2010 8
2011 4
2012 3
2013 5
2014 8
2015 4
2016 2
2017 4
2018 10
2019 5
2020 11
2021 15
2022 5
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Alectinib.
Herden M, Waller CF. Herden M, et al. Among authors: waller cf. Recent Results Cancer Res. 2018;211:247-256. doi: 10.1007/978-3-319-91442-8_17. Recent Results Cancer Res. 2018. PMID: 30069772 Review.
Afatinib.
Wecker H, Waller CF. Wecker H, et al. Among authors: waller cf. Recent Results Cancer Res. 2018;211:199-215. doi: 10.1007/978-3-319-91442-8_14. Recent Results Cancer Res. 2018. PMID: 30069769 Review.
Gefitinib.
Rawluk J, Waller CF. Rawluk J, et al. Among authors: waller cf. Recent Results Cancer Res. 2018;211:235-246. doi: 10.1007/978-3-319-91442-8_16. Recent Results Cancer Res. 2018. PMID: 30069771 Review.
Imatinib mesylate.
Waller CF. Waller CF. Recent Results Cancer Res. 2014;201:1-25. doi: 10.1007/978-3-642-54490-3_1. Recent Results Cancer Res. 2014. PMID: 24756783 Review.
Imatinib Mesylate.
Waller CF. Waller CF. Recent Results Cancer Res. 2018;212:1-27. doi: 10.1007/978-3-319-91439-8_1. Recent Results Cancer Res. 2018. PMID: 30069623
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial.
Aix SP, Ciuleanu TE, Navarro A, Cousin S, Bonanno L, Smit EF, Chiappori A, Olmedo ME, Horvath I, Grohé C, Farago AF, López-Vilariño JA, Cullell-Young M, Nieto A, Vasco N, Gómez J, Kahatt C, Zeaiter A, Carcereny E, Roubec J, Syrigos K, Lo G, Barneto I, Pope A, Sánchez A, Kattan J, Zarogoulidis K, Waller CF, Bischoff H, Juan-Vidal O, Reinmuth N, Dómine M, Paz-Ares L. Aix SP, et al. Among authors: waller cf. Lancet Respir Med. 2023 Jan;11(1):74-86. doi: 10.1016/S2213-2600(22)00309-5. Epub 2022 Oct 14. Lancet Respir Med. 2023. PMID: 36252599 Clinical Trial.
[Malignant pleural mesothelioma].
Ploenes T, Osei-Agyemang T, Nestle U, Waller CF, Passlick B. Ploenes T, et al. Among authors: waller cf. Dtsch Med Wochenschr. 2012 Mar;137(10):481-6. doi: 10.1055/s-0031-1298905. Epub 2012 Feb 28. Dtsch Med Wochenschr. 2012. PMID: 22374657 Review. German.
[Medicinal tumor treatment of oropharyngeal cancer].
Rawluk J, Waller CF. Rawluk J, et al. Among authors: waller cf. HNO. 2021 Apr;69(4):285-297. doi: 10.1007/s00106-021-01011-6. Epub 2021 Mar 3. HNO. 2021. PMID: 33660085 Review. German.
Imatinib mesylate.
Waller CF. Waller CF. Recent Results Cancer Res. 2010;184:3-20. doi: 10.1007/978-3-642-01222-8_1. Recent Results Cancer Res. 2010. PMID: 20072827 Review.
Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1-High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer.
Bischoff P, Reck M, Overbeck T, Christopoulos P, Rittmeyer A, Lüders H, Kollmeier J, Kulhavy J, Kemper M, Reinmuth N, Röper J, Janning M, Sommer L, Aguinarte L, Koch M, Wiesweg M, Wesseler C, Waller CF, Kauffmann-Guerrero D, Stenzinger A, Stephan-Falkenau S, Trautmann M, Lassmann S, Tiemann M, Klauschen F, Sebastian M, Griesinger F, Wolf J, Loges S, Frost N; National Network Genomic Medicine Lung Cancer (nNGM) Collaborator Group. Bischoff P, et al. Among authors: waller cf. J Thorac Oncol. 2023 Dec 13:S1556-0864(23)02423-1. doi: 10.1016/j.jtho.2023.12.015. Online ahead of print. J Thorac Oncol. 2023. PMID: 38096950 Free article.
120 results